Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus

NAActive, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

July 14, 2025

Study Completion Date

July 1, 2026

Conditions
Type 2 Diabetes
Interventions
DEVICE

Unblinded CGM plus nutrition therapy

"will receive evidence-based nutrition guidance by a certified and licensed registered dietitian (RD), including information on portion sizes, macronutrient types, and effect of carbohydrates on blood glucose.~will receive Dexcom G6 Pro CGMs to wear throughout the study. The CGM will be unblinded so that the glucose data will be available in real time to the participant and investigators. The dietitian and participant will review CGM data together"

BEHAVIORAL

Nutrition therapy only

will receive evidence-based nutrition guidance by a certified and licensed registered dietitian (RD), including information on portion sizes, macronutrient types, and effect of carbohydrates on blood glucose.

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT06465693 - Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter